ENDRA Life Sciences (NDRA) Projected to Post Quarterly Earnings on Thursday

ENDRA Life Sciences (NASDAQ:NDRA) is expected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($4.10) per share for the quarter.

ENDRA Life Sciences Stock Down 4.2 %

NASDAQ:NDRA opened at $4.30 on Wednesday. ENDRA Life Sciences has a 52-week low of $3.15 and a 52-week high of $1,750.00. The stock’s 50 day moving average price is $4.72 and its 200 day moving average price is $6.07. The company has a market capitalization of $2.31 million, a PE ratio of 0.00 and a beta of 0.43.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.